PT804562E - Factor 2 de crescimento de tecido conjuntivo - Google Patents
Factor 2 de crescimento de tecido conjuntivoInfo
- Publication number
- PT804562E PT804562E PT94925090T PT94925090T PT804562E PT 804562 E PT804562 E PT 804562E PT 94925090 T PT94925090 T PT 94925090T PT 94925090 T PT94925090 T PT 94925090T PT 804562 E PT804562 E PT 804562E
- Authority
- PT
- Portugal
- Prior art keywords
- polypeptide
- conjunctive tissue
- tissue growing
- growing factor
- enhancing
- Prior art date
Links
- 239000003102 growth factor Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 abstract 5
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 5
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000005557 antagonist Substances 0.000 abstract 1
- 239000007943 implant Substances 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 238000010188 recombinant method Methods 0.000 abstract 1
- 230000006641 stabilisation Effects 0.000 abstract 1
- 238000011105 stabilization Methods 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/US1994/007736 WO1996001896A1 (en) | 1994-07-12 | 1994-07-12 | Connective tissue growth factor-2 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT804562E true PT804562E (pt) | 2003-02-28 |
Family
ID=22242737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT94925090T PT804562E (pt) | 1994-07-12 | 1994-07-12 | Factor 2 de crescimento de tecido conjuntivo |
Country Status (10)
| Country | Link |
|---|---|
| US (5) | US5945300A (pt) |
| EP (2) | EP1217067A2 (pt) |
| JP (1) | JPH10502534A (pt) |
| AT (1) | ATE225850T1 (pt) |
| AU (1) | AU689492B2 (pt) |
| DE (1) | DE69431534T2 (pt) |
| DK (1) | DK0804562T3 (pt) |
| NZ (1) | NZ271488A (pt) |
| PT (1) | PT804562E (pt) |
| WO (1) | WO1996001896A1 (pt) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT804562E (pt) * | 1994-07-12 | 2003-02-28 | Human Genome Sciences Inc | Factor 2 de crescimento de tecido conjuntivo |
| US20090081228A1 (en) * | 1996-03-15 | 2009-03-26 | Munin Corporation | Cyr61 compositions and methods |
| DK0888452T3 (da) | 1996-03-15 | 2004-06-14 | Munin Corp | Human CYR61, et ekstracellulært matrix-signalmolekyle |
| US7521540B2 (en) | 1996-03-15 | 2009-04-21 | Munin Corporation | CYR61 compositions and methods |
| US6790606B1 (en) | 1996-03-15 | 2004-09-14 | Munin Corporation | Extracellular matrix signaling molecules |
| AU2004202578B2 (en) * | 1996-03-15 | 2007-09-13 | Munin Corporation | Extracellular matrix signalling molecules |
| US20040132987A1 (en) | 1996-11-08 | 2004-07-08 | Human Genome Sciences, Inc. | Connective tissue growth factor-3 |
| CA2286934A1 (en) * | 1997-04-16 | 1998-10-22 | Millennium Biotherapeutics, Inc. | Novel polypeptides within the growth factor superfamily |
| DE19719652A1 (de) * | 1997-05-09 | 1998-12-03 | Merckle Gmbh | Tissue-Faktor zur Förderung von Wundheilung |
| US6416974B1 (en) | 1997-08-06 | 2002-07-09 | Millennium Pharmaceuticals, Inc. | Tango 71 nucleic acids |
| US5876730A (en) * | 1997-08-07 | 1999-03-02 | Childrens Hospital Research Foundation | Heparin-binding growth factor (HBGF) polypeptides |
| AU2870399A (en) * | 1998-02-20 | 1999-09-06 | Zymogenetics Inc. | Connective tissue growth factor homologs |
| US6378527B1 (en) * | 1998-04-08 | 2002-04-30 | Chondros, Inc. | Cell-culture and polymer constructs |
| US7115390B1 (en) * | 1998-12-14 | 2006-10-03 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
| AU775391B2 (en) * | 1998-12-14 | 2004-07-29 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
| EP1892250A3 (en) * | 2000-01-31 | 2008-09-17 | Munin Corporation | CYR61 compositions and methods |
| US20060052328A1 (en) * | 2000-07-11 | 2006-03-09 | Human Genome Sciences, Inc. | Connective tissue growth factor-2 |
| US20050153395A1 (en) * | 2003-09-29 | 2005-07-14 | Children's Hospital Inc. | Unique integrin binding site in connective tissue growth factor (CTGF) |
| TW201102086A (en) | 2009-06-04 | 2011-01-16 | Hoffmann La Roche | Antibodies against human CCN1 and uses thereof |
| WO2011107590A1 (en) * | 2010-03-04 | 2011-09-09 | Wolfgang Poller | Cnn1 (cyr61) for prevention and therapy of inflammatory disease |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988003409A1 (en) | 1986-11-14 | 1988-05-19 | Institute Of Molecular Biology, Inc. | Wound healing and bone regeneration |
| DK131988A (da) | 1988-03-11 | 1989-09-12 | Erasmus University | Igf-bindingsprotein, dna-struktur, der koder for igf-bindingsproteinet og vektor indeholdende denne dna-struktur |
| US5648461A (en) * | 1990-02-22 | 1997-07-15 | W.R. Grace & Co.-Conn | Synthetic analogs of thrombospondin and therapeutic use thereof |
| JPH05255397A (ja) * | 1991-01-18 | 1993-10-05 | Bristol Myers Squibb Co | ＴＧＦ−β誘導遺伝子系統群 |
| US5837258A (en) | 1991-08-30 | 1998-11-17 | University Of South Florida | Induction of tissue, bone or cartilage formation using connective tissue growth factor |
| US5408040A (en) * | 1991-08-30 | 1995-04-18 | University Of South Florida | Connective tissue growth factor(CTGF) |
| US5270170A (en) * | 1991-10-16 | 1993-12-14 | Affymax Technologies N.V. | Peptide library and screening method |
| WO1994003599A1 (en) | 1992-08-04 | 1994-02-17 | Sagami Chemical Research Center | HUMAN cDNA AND PROTEIN WHICH SAID cDNA CODES FOR |
| PT804562E (pt) * | 1994-07-12 | 2003-02-28 | Human Genome Sciences Inc | Factor 2 de crescimento de tecido conjuntivo |
| US7026299B2 (en) * | 1994-07-12 | 2006-04-11 | Human Genome Sciences, Inc. | Connective tissue growth factor-2 |
| US5792453A (en) | 1995-02-28 | 1998-08-11 | The Regents Of The University Of California | Gene transfer-mediated angiogenesis therapy |
| DK0888452T3 (da) | 1996-03-15 | 2004-06-14 | Munin Corp | Human CYR61, et ekstracellulært matrix-signalmolekyle |
| US5944710A (en) | 1996-06-24 | 1999-08-31 | Genetronics, Inc. | Electroporation-mediated intravascular delivery |
| AU775391B2 (en) | 1998-12-14 | 2004-07-29 | Fibrogen, Inc. | Connective tissue growth factor fragments and methods and uses thereof |
| US20060052328A1 (en) * | 2000-07-11 | 2006-03-09 | Human Genome Sciences, Inc. | Connective tissue growth factor-2 |
-
1994
- 1994-07-12 PT PT94925090T patent/PT804562E/pt unknown
- 1994-07-12 EP EP02000398A patent/EP1217067A2/en not_active Withdrawn
- 1994-07-12 EP EP94925090A patent/EP0804562B1/en not_active Expired - Lifetime
- 1994-07-12 AU AU75131/94A patent/AU689492B2/en not_active Ceased
- 1994-07-12 AT AT94925090T patent/ATE225850T1/de not_active IP Right Cessation
- 1994-07-12 DE DE69431534T patent/DE69431534T2/de not_active Expired - Fee Related
- 1994-07-12 WO PCT/US1994/007736 patent/WO1996001896A1/en active IP Right Grant
- 1994-07-12 JP JP8504265A patent/JPH10502534A/ja active Pending
- 1994-07-12 DK DK94925090T patent/DK0804562T3/da active
- 1994-07-12 NZ NZ271488A patent/NZ271488A/en not_active IP Right Cessation
-
1995
- 1995-06-02 US US08/459,101 patent/US5945300A/en not_active Expired - Fee Related
-
1999
- 1999-07-08 US US09/348,815 patent/US6534630B1/en not_active Expired - Fee Related
-
2002
- 2002-11-15 US US10/294,796 patent/US20030078391A1/en not_active Abandoned
-
2006
- 2006-11-28 US US11/563,870 patent/US20070154908A1/en not_active Abandoned
-
2009
- 2009-10-15 US US12/579,542 patent/US20100041136A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP0804562A1 (en) | 1997-11-05 |
| US20100041136A1 (en) | 2010-02-18 |
| DK0804562T3 (da) | 2003-02-10 |
| US6534630B1 (en) | 2003-03-18 |
| DE69431534T2 (de) | 2003-06-26 |
| ATE225850T1 (de) | 2002-10-15 |
| AU689492B2 (en) | 1998-04-02 |
| US20030078391A1 (en) | 2003-04-24 |
| NZ271488A (en) | 1998-01-26 |
| EP0804562A4 (en) | 1998-08-05 |
| EP1217067A2 (en) | 2002-06-26 |
| AU7513194A (en) | 1996-02-09 |
| US5945300A (en) | 1999-08-31 |
| WO1996001896A1 (en) | 1996-01-25 |
| JPH10502534A (ja) | 1998-03-10 |
| DE69431534D1 (de) | 2002-11-14 |
| US20070154908A1 (en) | 2007-07-05 |
| EP0804562B1 (en) | 2002-10-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT804562E (pt) | Factor 2 de crescimento de tecido conjuntivo | |
| DK0759067T3 (da) | Transformerende vækstfaktor alfa-H1 | |
| DE10299044I1 (de) | n-Terminal chemisch modifizierte Protein-Zusammensetzungen und Methoden | |
| DE69433742D1 (de) | Bmp-10 zusammensetzungen | |
| DK0429570T3 (da) | Osteoinducerende præparater | |
| ATE309360T1 (de) | Vaskularer endothelialer wachstumsfaktor 2 | |
| DK0698094T3 (da) | BMP-11-sammensætninger | |
| DE69631544D1 (de) | Fettleibigkeitsprotein (ob) zur erhögung der mageren körpermasse | |
| ATE238417T1 (de) | Rekombinante knochenmorphogenetische protein heterodimere, zusammensetzungen und verfahren zur verwendung | |
| EP0787802A3 (pt) | ||
| ATE510552T1 (de) | Verfahren zur herstellung von sekretierte verkurzte varianten des humanen thyrotropinrezeptors | |
| ATE184917T1 (de) | Rekombinante methode und wirt zur herstellung von xylitol | |
| ATE167232T1 (de) | Protein mit knochenbildungs-eigenschaften und verfahren zu seiner herstellung | |
| ATE258933T1 (de) | Übergangszustand-analoga des kokains, ihre verwendung zur herstellung von kataltischen antikörpern gegen kokain und verwendung derselben in diagnose und therapie | |
| DE60025830D1 (de) | Fusions-polypeptide zur gewebegeneration und wundheilung zur gezielten matrixanwendung | |
| ES2167322T3 (es) | Proteina de tipo cadherinico relacionada con los huesos y procedimiento para su preparacion. | |
| WO2002004480A3 (en) | Connective tissue growth factor-2 | |
| DE69634994D1 (de) | Bindegewebe-wachstumsfaktor 3. | |
| ES2180585T3 (es) | Factor de crecimiento de tejido conjuntivo-2. | |
| RU95108616A (ru) | Способ лечения верхней ретро- или микрогнатии, осложненной расщелиной твердого неба и альвеолярного отростка |